1. Home
  2. TYRA vs CABO Comparison

TYRA vs CABO Comparison

Compare TYRA & CABO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TYRA
  • CABO
  • Stock Information
  • Founded
  • TYRA 2018
  • CABO 1980
  • Country
  • TYRA United States
  • CABO United States
  • Employees
  • TYRA N/A
  • CABO N/A
  • Industry
  • TYRA Biotechnology: Pharmaceutical Preparations
  • CABO Cable & Other Pay Television Services
  • Sector
  • TYRA Health Care
  • CABO Telecommunications
  • Exchange
  • TYRA Nasdaq
  • CABO Nasdaq
  • Market Cap
  • TYRA 844.2M
  • CABO 748.3M
  • IPO Year
  • TYRA 2021
  • CABO N/A
  • Fundamental
  • Price
  • TYRA $14.27
  • CABO $130.96
  • Analyst Decision
  • TYRA Strong Buy
  • CABO Hold
  • Analyst Count
  • TYRA 5
  • CABO 3
  • Target Price
  • TYRA $31.20
  • CABO $164.50
  • AVG Volume (30 Days)
  • TYRA 261.6K
  • CABO 93.5K
  • Earning Date
  • TYRA 11-05-2025
  • CABO 11-06-2025
  • Dividend Yield
  • TYRA N/A
  • CABO 4.49%
  • EPS Growth
  • TYRA N/A
  • CABO N/A
  • EPS
  • TYRA N/A
  • CABO N/A
  • Revenue
  • TYRA N/A
  • CABO $1,524,898,000.00
  • Revenue This Year
  • TYRA N/A
  • CABO N/A
  • Revenue Next Year
  • TYRA N/A
  • CABO N/A
  • P/E Ratio
  • TYRA N/A
  • CABO N/A
  • Revenue Growth
  • TYRA N/A
  • CABO N/A
  • 52 Week Low
  • TYRA $6.42
  • CABO $116.13
  • 52 Week High
  • TYRA $17.78
  • CABO $437.00
  • Technical
  • Relative Strength Index (RSI)
  • TYRA 49.37
  • CABO 30.20
  • Support Level
  • TYRA $13.35
  • CABO $136.80
  • Resistance Level
  • TYRA $15.38
  • CABO $145.22
  • Average True Range (ATR)
  • TYRA 0.92
  • CABO 8.54
  • MACD
  • TYRA -0.14
  • CABO -2.75
  • Stochastic Oscillator
  • TYRA 35.37
  • CABO 26.81

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About CABO Cable One Inc.

Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.

Share on Social Networks: